Nadav Kidron serves as Chief Executive Officer of Oramed Pharmaceuticals, which he co-founded in 2006. Their orally-taken insulin is game-changing technology that could revolutionize the way millions people with diabetes administer their medication. Kidron has led everything from establishing the company, to seeking capital, to recruiting top talent from the business, financial, technical and strategic spheres. […]